ST-segment Elevation Myocardial Infarction (STEMI): Clinical Trials

1 trial for ST-segment Elevation Myocardial Infarction (STEMI), newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed. 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 21Completed 1
Phase 31Completed 1

Follow ST-segment Elevation Myocardial Infarction (STEMI): new trials by email Literature Review of ST-segment Elevation Myocardial Infarction (STEMI) trials Research Report on ST-segment Elevation Myocardial Infarction (STEMI)

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Pharmacoinvasive Therapy With Prourokinase
Prourokinase, Placebo - ST-segment Elevation Myocardial Infarction (STEMI)
Phase 2 / Phase 3CompletedSuzhou Landing Pharmaceuticals1972008-11-012012-07-27

Narrower conditions

ST Elevation Myocardial Infarction (1)

Broader conditions

Cardiovascular Diseases (1)  ·  Heart Diseases (1)  ·  Infarction (1)  ·  Ischemia (1)  ·  Myocardial Infarction (1)  ·  Myocardial Ischemia (1)  ·  Necrosis (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)  ·  Vascular Diseases (1)

Interventions

saruplase (1)

Sponsors

Suzhou Landing Pharmaceuticals (1)

Countries

China (1)

Results publications

PMID 23634911